138 related articles for article (PubMed ID: 8587250)
21. A Japanese family with Alport syndrome associated with esophageal leiomyomatosis: genetic analysis of COL4A5 to COL4A6 and immunostaining for type IV collagen subtypes.
Sugimoto K; Yanagida H; Yagi K; Kuwajima H; Okada M; Takemura T
Clin Nephrol; 2005 Aug; 64(2):144-50. PubMed ID: 16114791
[TBL] [Abstract][Full Text] [Related]
22. [Diffuse leiomyomatosis with genital involvement and Alport syndrome. Report of two cases].
Le Bras A; David A; Knipping M; Mensier A; Heidet L; Lopes P
J Gynecol Obstet Biol Reprod (Paris); 1998 Sep; 27(5):523-8. PubMed ID: 9791580
[TBL] [Abstract][Full Text] [Related]
23. [Esophageal leiomyomatosis revealing an Alport syndrome].
Abbes K; Ayadi L; Makni S; Kharrat M; Affes N; Kallel R; Gouiaa N; Ben Hmida M; Hachicha J; Beyrouti MI; Sellami Boudawara T
Rev Med Interne; 2009 Jan; 30(1):88-90. PubMed ID: 18433941
[TBL] [Abstract][Full Text] [Related]
24. Mutations in Alport syndrome associated with diffuse esophageal leiomyomatosis.
Antignac C; Heidet L
Contrib Nephrol; 1996; 117():172-82. PubMed ID: 8801045
[No Abstract] [Full Text] [Related]
25. Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.
Kashtan CE
Medicine (Baltimore); 1999 Sep; 78(5):338-60. PubMed ID: 10499074
[TBL] [Abstract][Full Text] [Related]
26. Organization and expression of basement membrane collagen IV genes and their roles in human disorders.
Sado Y; Kagawa M; Naito I; Ueki Y; Seki T; Momota R; Oohashi T; Ninomiya Y
J Biochem; 1998 May; 123(5):767-76. PubMed ID: 9562604
[TBL] [Abstract][Full Text] [Related]
27. Alport syndrome and diffuse leiomyomatosis with major morbid events presenting at adult age.
Van Loo A; Vanholder R; Buytaert I; De Paepe A; Praet M; Elewaut A; Lameire N
Nephrol Dial Transplant; 1997 Apr; 12(4):776-80. PubMed ID: 9141011
[No Abstract] [Full Text] [Related]
28. Identification of 17 mutations in ten exons in the COL4A5 collagen gene, but no mutations found in four exons in COL4A6: a study of 250 patients with hematuria and suspected of having Alport syndrome.
Heiskari N; Zhang X; Zhou J; Leinonen A; Barker D; Gregory M; Atkin CL; Netzer KO; Weber M; Reeders S; Grönhagen-Riska C; Neumann HP; Trembath R; Tryggvason K
J Am Soc Nephrol; 1996 May; 7(5):702-9. PubMed ID: 8738805
[TBL] [Abstract][Full Text] [Related]
29. Clinical Manifestations of Alport Syndrome-Diffuse Leiomyomatosis Patients With Contiguous Gene Deletions in
Zhou X; Wang J; Mao J; Ye Q
Front Med (Lausanne); 2021; 8():766224. PubMed ID: 34778325
[TBL] [Abstract][Full Text] [Related]
30. Alport syndrome and leiomyomatosis: the first deletion extending beyond COL4A6 intron 2.
Uliana V; Marcocci E; Mucciolo M; Meloni I; Izzi C; Manno C; Bruttini M; Mari F; Scolari F; Renieri A; Salviati L
Pediatr Nephrol; 2011 May; 26(5):717-24. PubMed ID: 21380622
[TBL] [Abstract][Full Text] [Related]
31. Deletions of the COL4A5 gene in patients with Alport syndrome.
Netzer KO; Renders L; Zhou J; Pullig O; Tryggvason K; Weber M
Kidney Int; 1992 Dec; 42(6):1336-44. PubMed ID: 1474765
[TBL] [Abstract][Full Text] [Related]
32. Identification of mutations in the COL4A5 collagen gene in Alport syndrome.
Barker DF; Hostikka SL; Zhou J; Chow LT; Oliphant AR; Gerken SC; Gregory MC; Skolnick MH; Atkin CL; Tryggvason K
Science; 1990 Jun; 248(4960):1224-7. PubMed ID: 2349482
[TBL] [Abstract][Full Text] [Related]
33. Chinese family with diffuse oesophageal leiomyomatosis: a new COL4A5/COL4A6 deletion and a case of gonosomal mosaicism.
Liu W; Wong JK; He Q; Wong EH; Tang CS; Zhang R; So MT; Wong KK; Nicholls J; Cherny SS; Sham PC; Tam PK; Garcia-Barcelo MM; Xia H
BMC Med Genet; 2015 Jul; 16():49. PubMed ID: 26179878
[TBL] [Abstract][Full Text] [Related]
34. COL4A5 deletions in three patients with Alport syndrome and posttransplant antiglomerular basement membrane nephritis.
Ding J; Zhou J; Tryggvason K; Kashtan CE
J Am Soc Nephrol; 1994 Aug; 5(2):161-8. PubMed ID: 7993995
[TBL] [Abstract][Full Text] [Related]
35. Clinical and molecular diagnosis of Alport syndrome.
Kashtan CE
Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
[TBL] [Abstract][Full Text] [Related]
36. Alport-leiomyomatosis syndrome: an update.
García-Torres R; Orozco L
Am J Kidney Dis; 1993 Nov; 22(5):641-8. PubMed ID: 8238008
[TBL] [Abstract][Full Text] [Related]
37. A nonsense mutation in the COL4A5 collagen gene in a family with X-linked juvenile Alport syndrome.
Hertz JM; Heiskari N; Zhou J; Jensen UB; Tryggvason K
Kidney Int; 1995 Jan; 47(1):327-32. PubMed ID: 7731166
[TBL] [Abstract][Full Text] [Related]
38. LINE-1 elements at the sites of molecular rearrangements in Alport syndrome-diffuse leiomyomatosis.
Segal Y; Peissel B; Renieri A; de Marchi M; Ballabio A; Pei Y; Zhou J
Am J Hum Genet; 1999 Jan; 64(1):62-9. PubMed ID: 9915944
[TBL] [Abstract][Full Text] [Related]
39. The clinical spectrum of type IV collagen mutations.
Lemmink HH; Schröder CH; Monnens LA; Smeets HJ
Hum Mutat; 1997; 9(6):477-99. PubMed ID: 9195222
[TBL] [Abstract][Full Text] [Related]
40. [A case report of Alport syndrome with esophageal leiomyomatosis].
Chen Y; Li SL; Xiao HJ; Ding J
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):611. PubMed ID: 18082056
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
